Sterling Capital Management’s Taro Pharmaceutical Industries Ltd. TARO Stock Holding History

Sterling Capital Management’s Portfolio TARO Stock Details TARO Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2017 Q3	–	Sell	-5,300	Closed	-$594K	–	987
2017 Q2	$594K	Hold	5,300	–	–	0.01%	760
2017 Q1	$618K	Hold	5,300	–	–	0.01%	757
2016 Q4	$558K	Hold	5,300	–	–	0.01%	763
2016 Q3	$586K	Buy	5,300 +650	+14%	+$86.1K	0.01%	712
2016 Q2	$677K	Buy	+4,650	New	+$659K	0.01%	646

Other funds holding TARO

MICM

Matthews International Capital Management San Francisco, California $246M AUM 10.45% 1-Year Est. Return

Schroder Investment Management Group London, United Kingdom $122B AUM 29.27% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

APG Asset Management Amsterdam, Netherlands $31.6B AUM 19.33% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return

Norges Bank Oslo, Norway $935B AUM

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

AJO LP Philadelphia, Pennsylvania $199M AUM 109.68% 1-Year Est. Return

Sterling Capital Management's TARO Position: Q3 2017 in Review

Sterling Capital Management sold out of Taro Pharmaceutical Industries Ltd. (TARO) in Q3 2017, closing a stake of 5,300 shares — an estimated $594K sold.

Sterling Capital Management first reported a position in TARO in Q2 2016 and held it in 5 quarters. The position peaked at $677K in Q2 2016. 133 funds tracked by Wall St. Rank hold TARO as of Q3 2017.

Sterling Capital Management reported no remaining Taro Pharmaceutical Industries Ltd. position as of Q3 2017 after selling out during the quarter.
Sterling Capital Management sold 5,300 Taro Pharmaceutical Industries Ltd. shares in Q3 2017, an estimated $594K.
Sterling Capital Management first reported a position in Taro Pharmaceutical Industries Ltd. in Q2 2016 and held it in 5 quarters.
Sterling Capital Management's Taro Pharmaceutical Industries Ltd. position peaked at $677K in Q2 2016.
133 funds tracked by Wall St. Rank held Taro Pharmaceutical Industries Ltd. as of Q3 2017.

Based on Sterling Capital Management's 13F filing for Q3 2017, filed 15 Nov 2017.